- Home
- POWW vs OBIO Comparison
POWW vs OBIO Comparison
Compare POWW & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POWW
- OBIO
- Stock Information
- Founded
- POWW 1990
- OBIO 2017
- Country
- POWW United States
- OBIO United States
- Employees
- POWW N/A
- OBIO N/A
- Industry
- POWW Ordnance And Accessories
- OBIO Medicinal Chemicals and Botanical Products
- Sector
- POWW Industrials
- OBIO Health Care
- Exchange
- POWW Nasdaq
- OBIO Nasdaq
- Market Cap
- POWW 167.5M
- OBIO 146.2M
- IPO Year
- POWW N/A
- OBIO N/A
- Fundamental
- Price
- POWW $1.45
- OBIO $2.75
- Analyst Decision
- POWW Buy
- OBIO Strong Buy
- Analyst Count
- POWW 2
- OBIO 4
- Target Price
- POWW $1.75
- OBIO $14.00
- AVG Volume (30 Days)
- POWW 726.1K
- OBIO 224.0K
- Earning Date
- POWW 08-08-2025
- OBIO 11-11-2025
- Dividend Yield
- POWW N/A
- OBIO N/A
- EPS Growth
- POWW N/A
- OBIO N/A
- EPS
- POWW N/A
- OBIO N/A
- Revenue
- POWW $44,004,480.00
- OBIO $2,944,000.00
- Revenue This Year
- POWW $8.25
- OBIO $29.26
- Revenue Next Year
- POWW $0.74
- OBIO $10.65
- P/E Ratio
- POWW N/A
- OBIO N/A
- Revenue Growth
- POWW 62.90
- OBIO 41.61
- 52 Week Low
- POWW $0.95
- OBIO $2.20
- 52 Week High
- POWW $2.14
- OBIO $6.50
- Technical
- Relative Strength Index (RSI)
- POWW 51.09
- OBIO 61.42
- Support Level
- POWW $1.44
- OBIO $2.20
- Resistance Level
- POWW $1.51
- OBIO $2.89
- Average True Range (ATR)
- POWW 0.08
- OBIO 0.14
- MACD
- POWW -0.01
- OBIO 0.04
- Stochastic Oscillator
- POWW 26.09
- OBIO 82.61
About POWW AMMO Inc.
Outdoor Holding Co Formerly AMMO Inc is the owner of GunBroker.com, the online marketplace serving the firearms and shooting sports industries, and a vertically integrated producer of high-performance ammunition and components. It engages in the design, manufacture, and market of ammunition products in the Shooting sports industry in the United States. The firm's product segment comprises Ammunition and Marketplace. The Ammunition segment engages in the design, production, and marketing of ammunition and ammunition component products and the marketplace segment consists of the GunBroker.com marketplace. The company generates the majority of its revenue from the Ammunition segment.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.